top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Adverse effects of pertussis and rubella vaccines [[electronic resource] ] : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1991
Descrizione fisica 1 online resource (xii, 367 pages) : illustrations
Disciplina 615/.372
Altri autori (Persone) HowsonChristopher Paul
HoweCynthia J
FinebergHarvey V
Soggetto topico Pertussis vaccines - Side effects
Rubella vaccines - Side effects
Whooping cough - Vaccination - Complications
Rubella - Vaccination - Complications
Soggetto genere / forma Electronic books.
ISBN 1-280-20370-6
9786610203703
0-309-55597-3
0-585-03433-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910456250803321
Washington, D.C., : National Academy Press, 1991
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / editors, Christopher P. Howson, Cynthia J. Howe, Harvey V. Fineberg
Pubbl/distr/stampa Washington, D.C. : , : National Academy Press, , 1991
Descrizione fisica 1 online resource (xii, 367 pages) : illustrations
Disciplina 615/.372
Altri autori (Persone) HowsonChristopher Paul
HoweCynthia J
FinebergHarvey V
Soggetto topico Pertussis vaccines - Side effects
Rubella vaccines - Side effects
Whooping cough - Vaccination - Complications
Rubella - Vaccination - Complications
ISBN 1-280-20370-6
9786610203703
0-309-55597-3
0-585-03433-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910778503103321
Washington, D.C. : , : National Academy Press, , 1991
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Adverse effects of pertussis and rubella vaccines : a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines / / Christopher P. Howson, Cynthia J. Howe, and Harvey V. Fineberg, editors
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1991
Descrizione fisica 1 online resource (xii, 367 pages) : illustrations
Disciplina 615/.372
Altri autori (Persone) HowsonChristopher Paul
HoweCynthia J
FinebergHarvey V
Soggetto topico Pertussis vaccines - Side effects
Rubella vaccines - Side effects
Whooping cough - Vaccination - Complications
Rubella - Vaccination - Complications
ISBN 1-280-20370-6
9786610203703
0-309-55597-3
0-585-03433-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Adverse Effects of Pertussis and Rubella Vaccines -- Copyright -- Preface -- Acknowledgments -- Contents -- Adverse Effects of PERTUSSIS and RUBELLA Vaccines -- 1 Executive Summary -- METHODOLOGIC CONSIDERATIONS IN EVALUATING THE EVIDENCE -- SUMMARY AND CONCLUSIONS -- RESEARCH NEEDS -- 2 Histories of Pertussis and Rubella Vaccines -- PERTUSSIS VACCINES -- Epidemiology of Whooping Cough -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Causative Organism, B. pertussis -- Major Milestones in the Development of Pertussis Vaccines -- Whole-Cell Vaccines -- Acellular Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Pertussis Vaccination -- RUBELLA VACCINES -- Epidemiology of the Disease Rubella -- Clinical Description -- Diagnosis -- Complications -- Descriptive Epidemiology -- Nature of the Rubella Virus -- Major Milestones in the Development of Rubella Vaccines -- Brief History of the Controversy Pertaining to Adverse Events Following Rubella Vaccination -- REFERENCES -- 3 Methodologic Considerations in Evaluating the Evidence -- THE NATURE OF THE EVIDENCE -- QUESTIONS TO BE ADDRESSED -- (1) Can vaccine cause the adverse event? -- (2) How frequently does vaccine cause the event? -- (3) Did vaccination cause a particular case of the adverse event? -- THE BURDEN OF PROOF -- CATEGORIES OF EVIDENCE -- Experiments in Humans -- Randomized Controlled Trials -- Other Experimental Studies -- Experiments in Animals: Animal Models -- Controlled Epidemiologic Studies (Observational) -- Cohort Studies -- Case-Comparison Studies -- Other Controlled Studies -- Case Reports and Case Series -- Searching for Patterns -- Historical Comparisons -- Causation of the Individual Case -- Monitoring System for Adverse Events Following Immunization -- ASSESSMENT OF THE EVIDENCE.
Evaluation of Single Studies -- Integration of the Collective Results -- Meta-Analysis -- Considerations in Inferring Causality -- THE NATURE OF THE CONCLUSIONS -- Quantitation -- Resolution -- Uncertainty and Confidence -- Quality -- Comprehensiveness -- Neutrality -- Judgment -- SUMMARY OF THE EVIDENCE -- REFERENCES -- 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile... -- INFANTILE SPASMS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- HYPSARRHYTHMIA -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- ENCEPHALOPATHY -- Clinical Description -- Encephalopathy Following Whooping Cough -- Pathology -- Descriptive Epidemiology -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Case Series -- Studies in Defined Populations -- The National Childhood Encephalopathy Study -- Other Controlled Studies in Humans -- Evidence from Studies in Animals -- Aluminum Salts -- Summary -- Conclusion -- REFERENCES -- 5 Evidence Concerning Pertussis Vaccines and Deaths Classified as Sudden Infant Death Syndrome -- CLINICAL DESCRIPTION, DIAGNOSIS, AND PATHOLOGY -- DESCRIPTIVE EPIDEMIOLOGY.
HISTORY OF SUSPECTED ASSOCIATION WITH PERTUSSIS VACCINES -- EVIDENCE FROM STUDIES IN HUMANS -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- SUMMARY -- CONCLUSION -- REFERENCES -- 6 Evidence Concerning Pertussis Vaccines and Other Illnesses and Conditions -- ANAPHYLAXIS -- Clinical Description and Pathologic Aspects -- History of Suspected Association with Pertussis Vaccines -- Evidence from Studies in Humans -- Case Reports and Controlled Epidemiologic Studies -- Evidence from Studies in Animals -- Endotoxin -- Summary -- Conclusion -- AUTISM -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Summary -- Conclusion -- ERYTHEMA MULTIFORME OR OTHER RASH -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Aluminum Salts -- Summary -- Conclusion -- GUILLAIN-BARRÉ SYNDROME (POLYNEUROPATHY) -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- PERIPHERAL MONONEUROPATHY -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- HEMOLYTIC ANEMIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- JUVENILE DIABETES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Report -- Evidence from Studies in Animals -- Summary -- Conclusion -- LEARNING DISABILITIES AND HYPERACTIVITY -- Clinical Description -- Learning Disability, Reading Disability, and Dyslexia -- Hyperactivity, Hyperkinesis, and Attention Deficit Disorder -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Controlled Epidemiologic Studies -- Summary.
Conclusion -- PROTRACTED INCONSOLABLE CRYING AND SCREAMING -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusions -- REYE SYNDROME -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Controlled Epidemiologic Study -- Case Reports and Case Series -- Summary -- Conclusion -- SHOCK AND ''UNUSUAL SHOCK-LIKE STATE" WITH HYPOTONICITY, HYPORESPONSIVENESS, AND SHORT-LIVED CONVULS ... -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Controlled Epidemiologic Studies -- Summary -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- REFERENCES -- 7 Evidence Concerning Rubella Vaccines and Arthritis, Radiculoneuritis, and Thrombocytopenic Purpura -- ARTHRITIS -- Clinical Description and Pathologic Aspects -- Descriptive Epidemiology -- History of an Association with Rubella Vaccines -- Evidence from Studies in Humans -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Evidence from Studies in Animals -- Possible Mechanisms -- Summary -- Acute Arthropathy and Arthritis -- Chronic Arthritis -- Conclusions -- RADICULONEURITIS AND OTHER NEUROPATHIES -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports and Case Series -- Summary -- Conclusion -- THROMBOCYTOPENIC PURPURA -- Clinical Description -- Descriptive Epidemiology -- Evidence from Studies in Humans -- Case Reports -- Summary -- Conclusion -- REFERENCES -- Afterword on Research Needs -- Bibliography -- Glossary of Terms B -- Appendixes.
A Strategies For Gathering Information: Adverse Effects of Pertussis and Rubella Vaccines -- LITERATURE SEARCHES -- Electronic Data Bases -- OTHER SOURCES -- Reference Lists -- Presentations -- Public Meeting (January 10, 1990) -- Workshop (May 14, 1990) -- Committee Meeting (May 15, 1990) -- Additional Individuals and Organizations Who Provided Information -- Review of Interim Bibliography -- ABSTRACTION OF DATA FROM CASE REPORTS, CASE SERIES, AND CONTROLLED STUDIES -- Rationale -- Procedures for Abstraction and Adjudication of Study Data -- B Pertussis and Rubella Vaccines: A Brief Chronology -- PERTUSSIS VACCINES -- RUBELLA VACCINES -- REFERENCES -- C Animal Models for the Study of Whooping Cough and the Testing of Vaccine Materials -- ANIMAL MODELS FOR THE STUDY OF WHOOPING COUGH -- STANDARDIZED ANIMAL TESTS OF VACCINE MATERIALS -- REFERENCES -- D Technical Details of Power Calculations and Meta-Analyses -- POWER CALCULATIONS -- META-ANALYSES -- Formal Analysis -- Informal Analysis -- REFERENCES -- E Possible Involvement of Aluminum Salts in Erythema Multiforme, Encephalopathy, or Other Adverse E ... -- REFERENCES -- F Committee and Staff Biographies -- COMMITTEE -- STAFF -- Index.
Record Nr. UNINA-9910817001503321
Washington, D.C., : National Academy Press, 1991
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse events associated with childhood vaccines [[electronic resource] ] : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Adverse events associated with childhood vaccines [[electronic resource] ] : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1994
Descrizione fisica xvi, 464 p
Disciplina 615/.372/083
Altri autori (Persone) StrattonKathleen R
HoweCynthia J
JohnstonRichard B. <1935->
Soggetto topico Vaccination of children - Complications
Vaccines - Health aspects
Vaccines - Toxicology
Soggetto genere / forma Electronic books.
ISBN 1-280-19665-3
9786610196654
0-309-57632-6
0-585-15869-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910455874003321
Washington, D.C., : National Academy Press, 1994
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse events associated with childhood vaccines : evidence bearing on causality / / editors, Kathleen R. Stratton, Cynthia J. Howe, Richard B. Johnston, Jr
Adverse events associated with childhood vaccines : evidence bearing on causality / / editors, Kathleen R. Stratton, Cynthia J. Howe, Richard B. Johnston, Jr
Pubbl/distr/stampa Washington, D.C. : , : National Academy Press, , 1994
Descrizione fisica 1 online resource (480 pages)
Disciplina 615/.372/083
Altri autori (Persone) StrattonKathleen R
HoweCynthia J
JohnstonRichard B. <1935->
Soggetto topico Vaccination of children - Complications
Vaccines - Health aspects
Vaccines - Toxicology
ISBN 1-280-19665-3
9786610196654
0-309-57632-6
0-585-15869-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910778791603321
Washington, D.C. : , : National Academy Press, , 1994
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adverse events associated with childhood vaccines : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Adverse events associated with childhood vaccines : evidence bearing on causality / / Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1994
Descrizione fisica 1 online resource (480 pages)
Disciplina 615/.372/083
Altri autori (Persone) StrattonKathleen R
HoweCynthia J
JohnstonRichard B. <1935->
Soggetto topico Vaccination of children - Complications
Vaccines - Health aspects
Vaccines - Toxicology
ISBN 1-280-19665-3
9786610196654
0-309-57632-6
0-585-15869-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Adverse Events Associated with CHILDHOOD VACCINES -- Copyright -- Preface -- Acknowledgments -- Contents -- 1 Executive Summary -- BACKGROUND AND HISTORY -- THE CHARGE TO THE COMMITTEE -- THE STUDY PROCESS -- CAUSALITY AND WEIGHT OF EVIDENCE -- NEED FOR RESEARCH AND SURVEILLANCE -- REFERENCES -- 2 Causality and Evidence -- CAUSALITY -- Definitions -- Types of Causal Questions -- Can It? -- Did It? -- Will It? -- SOURCES OF EVIDENCE FOR CAUSALITY -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Combining the Evidence -- SUMMARIZING THE EVIDENCE FOR CAUSALITY -- REFERENCES -- 3 Neurologic Disorders -- DEMYELINATING DISEASE -- Experimental Models -- Acute Disseminated Encephalomyelitis -- Multiple Sclerosis -- Focal Lesions -- Guillain-Barré Syndrome -- Historical Background -- Clinical and Laboratory Features -- Diagnostic Criteria -- Antecedent Events -- Pathology and Pathogenesis -- Descriptive Epidemiology -- Summary of Demyelinating Diseases -- NON-DEMYELINATING DISEASE -- Encephalopathy -- Subacute Sclerosing Panencephalitis -- Clinical and Laboratory Features -- Pathology and Pathogenesis -- Descriptive Epidemiology -- Residual Seizure Disorder -- Sensorineural Deafness -- Neuropathy -- Mononeuropathy -- Brachial Neuritis -- REFERENCES -- 4 Immunologic Reactions -- ANAPHYLAXIS -- INTERACTION OF ANTIBODY WITH NORMAL TISSUE ANTIGENS -- ARTHUS REACTION -- DELAYED-TYPE HYPERSENSITIVITY -- EFFECT OF VACCINES ON THE IMMUNE SYSTEM -- REFERENCES -- 5 Diphtheria and Tetanus Toxoids -- BACKGROUND AND HISTORY -- Tetanus -- Diphtheria -- BIOLOGIC EVENTS FOLLOWING IMMUNIZATION -- Tetanus -- Diphtheria -- ENCEPHALOPATHY -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility.
Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- RESIDUAL SEIZURE DISORDER -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series. and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- GUILLAIN-BARRÉ SYNDROME -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- NEUROPATHY -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- ARTHRITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- ERYTHEMA MULTIFORME -- Clinical Description -- History of Suspected Association.
Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- ANAPHYLAXIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- DEATH -- Causality Argument -- Conclusion -- REFERENCES -- 6 Measles and Mumps Vaccines -- BACKGROUND AND HISTORY -- Measles -- Mumps -- BIOLOGIC EVENTS FOLLOWING IMMUNIZATION -- Measles -- Mumps -- ENCEPHALOPATHY AND ENCEPHALITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- ASEPTIC MENINGITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- SUBACUTE SCLEROSING PANENCEPHALITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- RESIDUAL SEIZURE DISORDER -- Clinical Description -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies.
Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- SENSORINEURAL DEAFNESS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- OPTIC NEURITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- TRANSVERSE MYELITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Studies, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- GUILLAIN-BARRÉ SYNDROME -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- INSULIN-DEPENDENT DIABETES MELLITUS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- STERILITY DUE TO ORCHITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies.
Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- THROMBOCYTOPENIA -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- ANAPHYLAXIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- DEATH -- Causality Argument -- Conclusion -- REFERENCES -- 7 Polio Vaccines -- BACKGROUND AND HISTORY -- BIOLOGIC EVENTS FOLLOWING IMMUNIZATION -- POLIOMYELITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors -- TRANSVERSE MYELITIS -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- GUILLAIN-BARRÉ SYNDROME -- Clinical Description -- History of Suspected Association -- Evidence for Association -- Biologic Plausibility -- Case Reports, Case Series, and Uncontrolled Observational Studies -- Controlled Observational Studies -- Controlled Clinical Trials -- Causality Argument -- Conclusion -- Risk-Modifying Factors.
ANAPHYLAXIS AND THROMBOCYTOPENIA.
Record Nr. UNINA-9910827558403321
Washington, D.C., : National Academy Press, 1994
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Fetal alcohol syndrome [[electronic resource] ] : diagnosis, epidemiology, prevention, and treatment / / Kathleen Stratton, Cynthia Howe, and Frederick Battaglia, editors ; Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
Fetal alcohol syndrome [[electronic resource] ] : diagnosis, epidemiology, prevention, and treatment / / Kathleen Stratton, Cynthia Howe, and Frederick Battaglia, editors ; Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1996
Descrizione fisica xvi, 213 p. : ill
Disciplina 618.3/268
Altri autori (Persone) StrattonKathleen R
HoweCynthia J
BattagliaFrederick C. <1932->
Soggetto topico Fetal alcohol syndrome
Fetus - Effect of drugs on
Soggetto genere / forma Electronic books.
ISBN 1-280-19306-9
9786610193066
0-309-57807-8
0-585-02638-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910456100003321
Washington, D.C., : National Academy Press, 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Fetal alcohol syndrome : diagnosis, epidemiology, prevention, and treatment / / Kathleen Stratton, Cynthia Howe, and Frederick Battaglia, editors ; Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
Fetal alcohol syndrome : diagnosis, epidemiology, prevention, and treatment / / Kathleen Stratton, Cynthia Howe, and Frederick Battaglia, editors ; Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
Pubbl/distr/stampa Washington, D.C. : , : National Academy Press, , 1996
Descrizione fisica 1 online resource (xvi, 213 pages) : illustrations
Disciplina 618.3/268
Altri autori (Persone) StrattonKathleen R
HoweCynthia J
BattagliaFrederick C. <1932->
Soggetto topico Fetal alcohol syndrome
Fetus - Effect of drugs on
ISBN 0-309-17612-3
1-280-19306-9
9786610193066
0-309-57807-8
0-585-02638-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910778661803321
Washington, D.C. : , : National Academy Press, , 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Fetal alcohol syndrome : diagnosis, epidemiology, prevention, and treatment / / Kathleen Stratton, Cynthia Howe, and Frederick Battaglia, editors ; Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
Fetal alcohol syndrome : diagnosis, epidemiology, prevention, and treatment / / Kathleen Stratton, Cynthia Howe, and Frederick Battaglia, editors ; Committee to Study Fetal Alcohol Syndrome, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine
Edizione [1st ed.]
Pubbl/distr/stampa Washington, D.C., : National Academy Press, 1996
Descrizione fisica 1 online resource (xvi, 213 pages) : illustrations
Disciplina 618.3/268
Altri autori (Persone) StrattonKathleen R
HoweCynthia J
BattagliaFrederick C. <1932->
Soggetto topico Fetal alcohol syndrome
Fetus - Effect of drugs on
ISBN 0-309-17612-3
1-280-19306-9
9786610193066
0-309-57807-8
0-585-02638-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Fetal Alcohol Syndrome -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- DIAGNOSIS AND CLINICAL EVALUATION OF FETAL ALCOHOL SYNDROME -- Key Recommendations -- EPIDEMIOLOGY AND SURVEILLANCE OF FAS, ARBD, AND ARND -- Key Conclusions and Recommendations -- EPIDEMIOLOGY AND SURVEILLANCE OF DRINKING DURING PREGNANCY -- Key Recommendations -- PREVENTION -- Key Recommendations -- Indicated Prevention Interventions -- Selective Prevention Interventions -- Universal Prevention Interventions -- TREATMENT OF THE AFFECTED INDIVIDUAL -- Key Recommendations -- INTEGRATION AND COORDINATION -- RECOMMENDATION -- 1 Introduction -- HISTORY -- THE FEDERAL RESPONSIBILITY FOR FAS RESEARCH -- CONGRESSIONAL INTEREST -- THE COMMITTEE'S FOCUS AND PROCESS -- SOME IMPORTANT DEFINITIONS -- REFERENCES -- 2 Issues in Research on Fetal Drug Effects -- PRINCIPLES OF TERATOLOGY AND DEVELOPMENTAL TOXICOLOGY -- SUSCEPTIBLE STAGES OF DEVELOPMENT -- SUSCEPTIBLE SPECIES AND GENOTYPE -- DOSE-RESPONSE EFFECTS -- INTERVENTION AND PREVENTION -- A MULTIFACTORIAL MODEL -- REFERENCES -- 3 Vignettes -- SALLY -- ANN -- LYDIA -- MARK AND JAMES -- PETER -- MARY -- BABY HERBERT'S MOTHER -- REFERENCES -- 4 Diagnosis and Clinical Evaluation of Fetal Alcohol Syndrome -- PURPOSE OF MEDICAL DIAGNOSES -- USE OF DIAGNOSTIC CRITERIA -- STANDARDS FOR EVALUATING DIAGNOSTIC CRITERIA -- ISSUES IN DECIDING ON DIAGNOSTIC CRITERIA -- SPECIFIC ISSUES TO BE ADDRESSED IN IDENTIFYING CRITERIA FOR FETAL ALCOHOL SYNDROME -- Exposure to Alcohol -- Defining Physical Features -- Behavioral or Cognitive Features -- Role of Ancillary Measures -- Diagnosis Across the Life Span -- Relationship of Fetal Alcohol Effects to Fetal Alcohol Syndrome -- EVOLUTION OF THE DIAGNOSIS OF FETAL ALCOHOL SYNDROME -- LONGITUDINAL PERSPECTIVES ON THE FAS DIAGNOSIS -- DIAGNOSTIC CATEGORIES.
DIFFERENTIAL DIAGNOSIS -- CLINICAL UTILITY OF FAS, ARBD, AND ARND DIAGNOSES -- Prevention -- Prevention of Secondary Disabilities -- RECOMMENDATIONS: DIAGNOSTIC CRITERIA -- REFERENCES -- 5 Epidemiology and Surveillance of Fetal Alcohol Syndrome -- INCIDENCE AND PREVALENCE OF FAS, ARBD, AND ARND -- Registry-Based Studies -- Clinic-Based Studies -- Prospective Epidemiologic Studies of the Effects of Maternal Substance Abuse -- Population-Based Epidemiology Studies -- Issues and Considerations -- Role of Epidemiology in Prevention Programs -- Consistent Diagnosis -- Use of Multiple Data Sources -- SURVEILLANCE METHODS FOR FETAL ALCOHOL SYNDROME -- Passive Surveillance -- Advantages and Disadvantages -- Possible Solutions -- Active Surveillance for Fetal Alcohol Syndrome -- Advantages and Disadvantages -- Proxy Measures in an Active Surveillance Program -- Feasibility of Surveillance -- CONCLUSIONS AND RECOMMENDATIONS -- REFERENCES -- 6 Epidemiology of Women's Drinking -- METHODOLOGIC CONSIDERATIONS -- Studies of Pregnant Women in Clinical Settings -- Studies of Pregnant Women in the General Population -- Other Issues -- DEFINITIONS AND PATTERNS OF DRINKING AMONG U.S. WOMEN -- Women in the General Population -- Pregnant Women -- Correlates of Drinking in Pregnancy -- NEEDED RESEARCH ON PREGNANT WOMEN'S DRINKING -- Increased Coordination of Research on FAS and Women's Drinking -- Increased Secondary Analysis of National Health and Alcohol Use Surveys -- Inclusion of Ethnic and Other Subgroup Populations in Studies of Drinking in Pregnancy -- Substance-Specific Versus Multiple-Substance Risk Factors -- CONCLUSIONS AND RECOMMENDATIONS -- REFERENCES -- 7 Prevention of Fetal Alcohol Syndrome -- A PUBLIC HEALTH MODEL OF PREVENTION -- Definitions -- UNIVERSAL PREVENTION INTERVENTIONS -- SELECTIVE PREVENTION INTERVENTIONS.
Population-Based Risk Factors for Giving Birth to an FAS Child -- Role of the Father -- Role of Health Care Professionals -- Screening Instruments -- Biomarkers -- Brief Interventions and Referral -- Professional Education -- Empirical Evaluation -- INDICATED PREVENTION INTERVENTIONS -- Women Who Have Given Birth to a Child with FAS, ARBD, or ARND -- Treatment of Alcohol Abuse and Dependence in Pregnant Women -- Treatment Outcome Research on Alcohol Abuse in Women -- Addressing Barriers to Research -- MAINTENANCE AND AFTERCARE -- PROGRAM EVALUATION -- PUBLIC HEALTH SERVICE-FUNDED RESEARCH -- SUMMARY -- RECOMMENDATIONS -- REFERENCES -- 8 The Affected Individual: Clinical Presentation, Intervention, and Treatment -- CLINICAL ISSUES IN INDIVIDUALS WITH FAS, ARBD, OR ARND -- Medical Overview: FAS Health Issues -- Behavioral and Social Issues -- Research Methodology -- Developmental Differences in Clinical Presentation -- Key Questions for Planning Interventions -- Patterns of Development -- Etiology -- Specificity -- INTERVENTION AND PREVENTION OF SECONDARY DISABILITIES -- Medical and Therapeutic Intervention -- Educational Interventions for Alcohol-Affected Children -- Other Interventions to Improve Outcomes for Affected Individuals -- Professional Training and Education of Policymakers -- Support for Families -- LIMITATIONS AND BARRIERS TO THE PROVISION OF SERVICES -- Accurate Identification -- Eligibility and Measurement of Development -- Inconsistency in Follow-Up -- SUMMARY: INTERVENTION AND TREATMENT -- RECOMMENDATIONS -- REFERENCES -- 9 Integration and Coordination: A Concluding Comment and Recommendation -- Appendix Biographies -- INSTITUTE OF MEDICINE STAFF -- Index.
Record Nr. UNINA-9910827547603321
Washington, D.C., : National Academy Press, 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Options for poliomyelitis vaccination in the United States [[electronic resource] ] : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors
Options for poliomyelitis vaccination in the United States [[electronic resource] ] : workshop summary / / Vaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors
Pubbl/distr/stampa Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996
Descrizione fisica 1 online resource (50 p.)
Disciplina 614.549
Altri autori (Persone) HoweCynthia J
JohnstonRichard B. <1935->
Soggetto topico Poliomyelitis vaccine - United States
Poliomyelitis - Prevention
Soggetto genere / forma Electronic books.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ""Options for Poliomyelitis Vaccination in the United States""; ""Copyright""; ""Preface""; ""Contents""; ""Introduction""; ""History and Current Status""; ""U.S. EXPERIENCE ""; ""Recent Experience""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""EXPERIENCE IN OTHER PARTS OF THE AMERICAS""; ""Latin America""; ""Canada""; ""GLOBAL EXPERIENCE""; ""Options for Poliomyelitis Vaccination""; ""ORAL POLIOVIRUS VACCINE ONLY""; ""Vaccine Characteristics""; ""Current Use in the United States""; ""Immunity""; ""Safety""; ""INACTIVATED POLIOVIRUS VACCINE ONLY ""; ""Vaccine Characteristics""
""Current Use in the United States""""Immunity""; ""Safety""; ""IPV Experience in Western Europe""; ""General Comments""; ""SEQUENTIAL SCHEDULE FOR IPV AND OPV""; ""Public Health Experience""; ""Effect of a Sequential Series on the Occurrence of Vaccine-Associated Paralytic Poliomyelitis""; ""Immunogenicity and Shedding""; ""Summary""; ""PARENTAL CHOICE""; ""NO POLIO VACCINE ""; ""MODELING THE OPTIONS""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""Susceptible Population""; ""Remaining Questions""; ""Discussion""; ""Afterword""; ""References""; ""Abbreviations""; ""Workshop Agenda""
""INSTITUTE OF MEDICINE VACCINE SAFETY FORUM""""History and Current Status of Poliomyelitis Vaccines""; ""Poliomyelitis Vaccine Characteristics""; ""Options for Poliomyelitis Vaccination""; ""CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Implementation Issues for Poliomyelitis Vaccination""; ""Considering the Options for Poliomyelitis Vaccination""; ""Discussion and Summary""; ""Workshop Speakers""; ""INSTITUTE OF MEDICINE AND CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Speakers and Session Chairs""
Record Nr. UNINA-9910451817203321
Washington, D.C. (2101 Constitution Ave., N.W., Washington 20418), : National Academy Press, 1996
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui